Reducing Health Disparities Among Minority and Underserved Children (R21 Clinical Trial Optional) | PA 18 169

Opportunity Information: Apply for PA 18 169

The National Institutes of Health (NIH) funding opportunity "Reducing Health Disparities Among Minority and Underserved Children (R21 Clinical Trial Optional)" (Funding Opportunity Number PA-18-169) supports early-stage, exploratory research aimed at understanding and reducing health disparities affecting children, particularly those from minority and underserved populations. The overall goal is to generate new knowledge, test promising ideas, and build the evidence base for strategies that can improve child health outcomes and narrow persistent gaps linked to race, ethnicity, socioeconomic status, geography, disability status, and other structural or contextual factors. A central theme of the announcement is the importance of investing in early childhood and developmental periods, where prevention and timely intervention can produce long-term benefits across the lifespan.

The research scope is intentionally broad but centered on work that directly addresses why disparities occur and what can be done to reduce them. One major focus is bio-behavioral research that integrates multiple, interacting drivers of child health disparities rather than studying factors in isolation. NIH highlights multi-level influences such as biological contributors (including genetics, cellular processes, and organ-system functioning), lifestyle and health behaviors, and environmental conditions spanning both physical settings and family environments. The opportunity also emphasizes social influences (for example, peer relationships and social networks), economic pressures, institutional factors (such as how schools, healthcare systems, and other organizations shape access and quality), and cultural and family influences that can affect development, risk exposure, resilience, and engagement with health services. Projects that treat these influences as interconnected and examine pathways across levels (biological to social to structural) are particularly aligned with the intent of the program.

Another targeted area includes studies designed around the health promotion needs of children who already have a diagnosed health condition and/or disability. In this context, the program encourages research that recognizes that disparities are not only about disease incidence, but also about differences in management, access to supportive services, prevention of complications, and quality of life. This can include work that tailors health promotion strategies to specific populations of children with chronic illnesses, developmental conditions, or disabilities, especially where underserved communities face additional barriers to consistent care, accommodations, or effective family-centered supports.

The announcement also calls for studies that test, evaluate, translate, and disseminate prevention, health promotion, and intervention approaches in both traditional and non-traditional settings. Traditional settings may include clinical and hospital environments, primary care, and school health programs. Non-traditional settings can include community centers, early childcare programs, faith-based spaces, home-based contexts, social service organizations, and other real-world venues where children and families spend time and where health-related behaviors and supports can be shaped. This emphasis reflects an interest in interventions that are feasible outside specialized research environments, can be delivered where underserved families can realistically access them, and can be scaled or adapted to reduce inequities in reach and impact. The notice specifies "clinical trial optional," meaning applicants may propose clinical trials but are not required to do so; the program is open to a range of study designs appropriate for early-stage or exploratory R21 research.

Funding is provided through the NIH R21 mechanism, which is typically used to support novel, exploratory, and developmental projects. The listed award ceiling is $200,000. While the source data does not specify the number of expected awards, the structure of the R21 indicates an emphasis on pilot testing, proof-of-concept research, preliminary intervention development, and early evaluation work that can position teams for larger follow-on studies and implementation efforts.

Eligibility is broad and includes many types of organizations and institutions capable of conducting health disparities research with children. Eligible applicants include state, county, and local governments; special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; public housing authorities/Indian housing authorities; and Native American tribal organizations that are not federally recognized tribal governments. Nonprofit organizations are eligible whether or not they hold 501(c)(3) status, and for-profit entities (other than small businesses) and small businesses may also apply. The opportunity explicitly notes additional eligible applicants such as Historically Black Colleges and Universities (HBCUs), Hispanic-serving institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, and Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), as well as faith-based or community-based organizations. It also allows certain non-U.S. entities (foreign organizations), regional organizations, U.S. territories or possessions, and Indian/Native American tribal governments that are not federally recognized, reflecting a desire to include organizations with direct connections to underserved communities and the capacity to conduct culturally grounded, community-engaged work.

Key administrative details from the source include: Opportunity Category "Discretionary," Funding Instrument Type "Grant," Activity Categories "Education" and "Health," and CFDA numbers 93.173 and 93.361. The opportunity was created on 2017-11-08, and the original closing date listed in the source data is 2020-05-07.

• The National Institutes of Health in the education, health sector is offering a public funding opportunity titled "Reducing Health Disparities Among Minority and Underserved Children (R21 Clinical Trial Optional)" and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.173, 93.361.
• This funding opportunity was created on 2017-11-08.
• Applicants must submit their applications by 2020-05-07. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
• Each selected applicant is eligible to receive up to $200,000.00 in funding.
• Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.

Apply for PA 18 169

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: